QUEST DIAGNOSTICS INC (DGX)
About QUEST DIAGNOSTICS INC
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $11.0B
- Net income
- $992.0M
- Total assets
- $16.2B
- Market cap
- $22.2B
- Gross margin
- 33.2%
- Operating margin
- 14.1%
- Net margin
- 9.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $11.0B
- Cost of revenue
- $7.4B
- Gross profit
- $3.7B
- Operating expenses
- $2.1B
- Operating income
- $1.6B
- Income tax
- $314.0M
- Net income
- $1.0B
- EPS (basic)
- $8.87
- EPS (diluted)
- $8.75
Balance sheet
- Total assets
- $16.2B
- Current assets
- $2.4B
- Total liabilities
- $8.9B
- Current liabilities
- $2.3B
- Shareholders’ equity
- $7.2B
Cash flow
- Operating cash flow
- $1.9B
- Investing cash flow
- -$631.0M
- Financing cash flow
- -$1.4B
- Net cash flow
- -$129.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $22.2B
- P/E ratio
- 26.0
- EPS (diluted)
- $8.75
- Dividend yield
- 1.51%
- Shares outstanding
- 97.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 17, 1996
Quest Diagnostics Inc (DGX) Stock Price
- Profitable — net income of $992.0M in FY2025.
- Revenue grew 2% from FY2021 to FY2025.
- Gross margin of 33.2%, net margin 9.5%.
- Trading near its 52-week high.
- Pays a dividend yielding about 1.51% annually.
- Valued at a price-to-earnings (P/E) ratio of 26.0.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review QUEST DIAGNOSTICS INC.
Write a review
News about QUEST DIAGNOSTICS INC
News & sentiment via Polygon.io
Quest Diagnostics Inc: frequently asked questions
Is Quest Diagnostics Inc an American company?
Yes — Quest Diagnostics Inc is an American company headquartered in Secaucus, New Jersey. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Quest Diagnostics Inc headquartered?
Quest Diagnostics Inc is headquartered in Secaucus, New Jersey, United States.
Is Quest Diagnostics Inc publicly traded?
Yes — Quest Diagnostics Inc is a publicly traded company. Its stock trades under the ticker symbol DGX on the NYSE.
What does Quest Diagnostics Inc do?
Quest Diagnostics Inc is an American Medical Devices company in the Health & Beauty sector.
When was Quest Diagnostics Inc founded?
Quest Diagnostics Inc was founded in 1967.
